Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - AIkido Pharma Inc.s103846_ex99-1.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

  

 

 

Date of Report (Date of earliest event reported): August 8, 2016

 

SPHERIX INCORPORATED

(Exact Name of Registrant as Specified in Charter)

 

Delaware   000-05576   52-0849320
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer Identification
No.)

 

One Rockefeller Plaza, 11th Floor
New York, NY
  10020
(Address of principal
executive offices)
  (Zip Code)

 

Registrant’s telephone number, including area code: (703) 992-9260

 

1350 Avenue of the Americas, FL 2, New York, NY 10019

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐       Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐       Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

       Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

       Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

Item 8.01 Other Events

 

On August 8, 2016, Spherix Incorporated (the “Company”) issued a press release announcing the closing of its previously announced underwritten public offering of 1,592,357 shares of its common stock at a fixed price to the public of $1.57 per share.

 

The press release is attached as Exhibit 99.1 to this report on Form 8-K and is incorporated herein by reference.

 

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

  99.1     Press Release issued by Spherix Incorporated on August 8, 2016
     

 

 
 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date:  August 8, 2016

 

    SPHERIX INCORPORATED
   

 

  By:   /s/ Anthony Hayes
    Name:  Anthony Hayes
    Title:  Chief Executive Officer